Ventricular septal defects (VSD) are congenital malformations characterized by an abnormal communication between the right and left ventricles. This pathological opening allows oxygenated blood to pass from the left to the right ventricle, causing a left-to-right shunt that leads to volume and pressure overload in the right heart and lungs. Although small VSDs may remain clinically silent, larger defects can lead to serious hemodynamic complications if not promptly treated.
Ventricular septal defects represent the most common form of congenital heart disease, accounting for about 20–30% of cases. The estimated prevalence is around 2–3 cases per 1,000 live births. In adults, an undiagnosed or uncorrected VSD may lead to heart failure, ventricular arrhythmias, and, in severe cases, Eisenmenger syndrome.
The etiology of ventricular septal defects is linked to errors in the complex embryological mechanisms that govern the formation of the interventricular septum. During fetal development, between the fourth and eighth weeks of gestation, the muscular and membranous septa must form and fuse properly to separate the two ventricles. Defects in these processes may result in a VSD, with location and size depending on the embryological region involved.
The main anatomical types of defects include:
VSDs may occur as isolated lesions or be part of complex syndromic patterns, such as Tetralogy of Fallot, common arterial trunk, or complete atrioventricular septal defect.
The key pathogenetic mechanism of VSDs is the left-to-right shunt, with oxygenated blood moving from the high-pressure left ventricle to the lower-pressure right ventricle. This shunt results in volume and pressure overload of the right heart and increased pulmonary blood flow.
Initially, the hemodynamic overload is compensated by right ventricular and pulmonary adaptation. However, persistent shunting progressively leads to right ventricular hypertrophy, thickening of pulmonary arteries, and elevated pulmonary vascular resistance.
When pulmonary resistance exceeds systemic resistance, the shunt may reverse (right-to-left), causing cyanosis (Eisenmenger syndrome), an irreversible and highly debilitating condition.
The main factors influencing the clinical severity of VSDs are:
In neonates with a large VSD, the clinical picture manifests early with signs of congestive heart failure. In contrast, in small VSDs, the shunt may remain asymptomatic and be incidentally diagnosed.
Ventricular septal defects are congenital malformations resulting from errors in cardiac morphogenesis, typically arising sporadically. However, certain genetic and environmental factors may increase the risk of developing the defect.
Key predisposing factors include:
Primary prevention of VSDs focuses on the strict control of pre-existing maternal diseases, adopting a healthy lifestyle before and during pregnancy, folic acid supplementation, and reducing exposure to teratogens. Nevertheless, even with optimal pregnancy management, it is not always possible to completely prevent the occurrence of a ventricular septal defect.
The clinical manifestations of ventricular septal defects strongly depend on the size of the defect and the extent of the hemodynamic shunt. While small VSDs may remain asymptomatic and be discovered incidentally, larger defects tend to present early with signs of heart failure.
In neonates and infants with significant VSDs, symptoms typically appear within the first few weeks of life. History may reveal:
In adults undiagnosed during childhood, symptoms may include exertional dyspnea, early fatigue, palpitations, and, in advanced cases, cyanosis from Eisenmenger syndrome.
The most characteristic finding in hemodynamically significant VSDs is the presence of a holosystolic murmur audible along the lower left sternal border. The murmur is typically high-pitched and radiates across the precordium. Paradoxically, smaller defects may produce a louder murmur compared to larger defects where the pressure gradient is reduced.
Other clinical signs may include:
The suspicion of ventricular septal defect should arise in the presence of a neonatal holosystolic murmur, early signs of heart failure, or recurrent respiratory symptoms without another apparent cause. Diagnosis must be confirmed and detailed through cardiac imaging techniques.
Transthoracic echocardiography is the first-line test. It allows direct visualization of the defect, quantification of the shunt using color Doppler, and assessment of chamber size and function. The Qp/Qs ratio quantifies the extent of pulmonary to systemic blood flow.
In adults or complex cases, transesophageal echocardiography provides superior resolution, offering better anatomical characterization, particularly for membranous or infundibular defects.
Cardiac magnetic resonance imaging (MRI) is useful in cases of complex anatomy or when a precise estimate of shunt volume is required. Cardiac catheterization is indicated in patients with suspected pulmonary hypertension, to directly measure pressures and ventricular gradients, and is essential for preoperative evaluation in advanced cases.
The rational diagnostic sequence includes: initial clinical suspicion based on auscultation and symptoms; confirmation with transthoracic echocardiography; further evaluation with transesophageal echocardiography or MRI in doubtful or complex cases; cardiac catheterization for hemodynamic characterization and therapeutic planning in patients with suspected pulmonary hypertension.
The treatment of ventricular septal defects depends on the size of the defect, the extent of the shunt, the hemodynamic impact, and the presence of complications. Small VSDs without significant hemodynamic overload may be monitored over time, as spontaneous closure is possible, especially in early childhood.
Defect correction is indicated in patients with:
Open-heart surgical closure remains the standard treatment for most hemodynamically significant VSDs. The operation is performed under cardiopulmonary bypass, with direct suture or patch application (using autologous pericardium or synthetic material). Operative mortality is very low in specialized centers, and long-term outcomes are excellent.
Percutaneous closure using occlusion devices is reserved for selected muscular defects or patients at high surgical risk. Not all types of VSD are suitable for this approach, and a careful anatomical assessment is crucial for procedural success.
The prognosis for patients undergoing early VSD closure is excellent, with long-term survival comparable to that of the general population. Early intervention allows for regression of right ventricular dilation and prevents the development of pulmonary hypertension and cardiac dysfunction.
In patients with untreated VSDs, the risk of complications increases with age, particularly if the defect is moderate or large. The onset of severe pulmonary hypertension, heart failure, or Eisenmenger syndrome significantly worsens the prognosis and limits therapeutic options.
The main complications associated with ventricular septal defects include:
Timely closure and accurate management allow for minimizing the risk of complications and ensuring optimal quality of life for patients.